Search details
1.
Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Carcinogenesis
; 41(5): 571-581, 2020 07 10.
Article
in English
| MEDLINE | ID: mdl-32648918
2.
Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Carcinogenesis
; 41(5): 571-581, 2020 07 10.
Article
in English
| MEDLINE | ID: mdl-32649753
3.
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Oncologist
; 25(10): e1552-e1561, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32663354
4.
Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
BMC Cancer
; 20(1): 487, 2020 May 29.
Article
in English
| MEDLINE | ID: mdl-32471389
5.
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial.
Gut
; 67(11): 2006-2016, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29802174
6.
Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
BMC Cancer
; 18(1): 815, 2018 Aug 13.
Article
in English
| MEDLINE | ID: mdl-30103712
7.
Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
BMC Cancer
; 18(1): 460, 2018 04 24.
Article
in English
| MEDLINE | ID: mdl-29690860
8.
A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
BMC Cancer
; 16: 137, 2016 Feb 22.
Article
in English
| MEDLINE | ID: mdl-26907597
9.
Adjuvant antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after curative treatment: A systematic review and meta-analysis.
Hepatol Res
; 46(1): 100-10, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26331530
10.
The prognostic value of combined TGF-ß1 and ELF in hepatocellular carcinoma.
BMC Cancer
; 15: 116, 2015 Mar 11.
Article
in English
| MEDLINE | ID: mdl-25880619
11.
Combined vascular resection and analysis of prognostic factors for hilar cholangiocarcinoma.
Hepatobiliary Pancreat Dis Int
; 14(6): 626-32, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26663011
12.
Risk factors and outcomes of postoperative pancreatic fistula after pancreatico-duodenectomy: an audit of 532 consecutive cases.
BMC Surg
; 15: 34, 2015 Mar 26.
Article
in English
| MEDLINE | ID: mdl-25887526
13.
Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
Ann Surg Oncol
; 21(12): 3802-9, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-24849520
14.
Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
BMC Cancer
; 14: 117, 2014 Feb 21.
Article
in English
| MEDLINE | ID: mdl-24559042
15.
Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
BMC Cancer
; 14: 104, 2014 Feb 18.
Article
in English
| MEDLINE | ID: mdl-24548704
16.
Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.
BMC Cancer
; 14: 744, 2014 Oct 03.
Article
in English
| MEDLINE | ID: mdl-25280428
17.
Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.
BMC Cancer
; 14: 571, 2014 Aug 07.
Article
in English
| MEDLINE | ID: mdl-25104140
18.
Radiofrequency-assisted versus clamp-crush liver resection: a systematic review and meta-analysis.
J Surg Res
; 187(2): 471-83, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24290429
19.
GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.
Hepatogastroenterology
; 61(130): 278-84, 2014.
Article
in English
| MEDLINE | ID: mdl-24901124
20.
Profile of regulatory T cells and interferon γ secretion in the tumor-draining lymph node from mouse Hepa1-6 cells.
J Surg Res
; 183(2): 900-6, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23481561